Translational research in stroke: taking advances in the pathophysiology and treatment of stroke from the experimental setting to clinical trials
- PMID: 17217852
- DOI: 10.1007/s11910-007-0019-1
Translational research in stroke: taking advances in the pathophysiology and treatment of stroke from the experimental setting to clinical trials
Abstract
Many advances have occurred regarding an increased understanding of the basic pathophysiology of ischemic brain injury that could lead to enhanced therapy for this disorder. Among the more important basic science advances are enhanced knowledge of the components of the ischemic cascade, the phenomenon of ischemic preconditioning, the potential relevance of hibernation, studies on gene expression in ischemic tissue, and imaging identification of the ischemic penumbra. The large number of unsuccessful prior clinical trials with a wide range of purported acute stroke therapies has provided many insights and lessons regarding how to perform better trials in the future. Translating these basic science and clinical trial design advances into effective and safe therapies will require increased interaction and cooperation between basic scientists and clinical researchers.
Similar articles
-
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717
-
Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.Pharmacol Biochem Behav. 2007 May;87(1):179-97. doi: 10.1016/j.pbb.2007.04.015. Epub 2007 May 4. Pharmacol Biochem Behav. 2007. PMID: 17521716 Review.
-
Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke.Neurol Res. 2012 May;34(4):331-7. doi: 10.1179/1743132812Y.0000000020. Neurol Res. 2012. PMID: 22643076 Review.
-
Oxygen therapy in acute ischemic stroke - experimental efficacy and molecular mechanisms.Curr Mol Med. 2009 Mar;9(2):227-41. doi: 10.2174/156652409787581619. Curr Mol Med. 2009. PMID: 19275631 Review.
-
Therapeutic hypothermia for acute ischemic stroke.Expert Rev Cardiovasc Ther. 2010 Apr;8(4):593-603. doi: 10.1586/erc.09.129. Expert Rev Cardiovasc Ther. 2010. PMID: 20397832 Review.
Cited by
-
A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.Neurosci Lett. 2016 Oct 28;633:7-13. doi: 10.1016/j.neulet.2016.08.048. Epub 2016 Aug 30. Neurosci Lett. 2016. PMID: 27589890 Free PMC article.
-
Nucleic Acid Therapies for Ischemic Stroke.Neurotherapeutics. 2019 Apr;16(2):299-313. doi: 10.1007/s13311-019-00710-x. Neurotherapeutics. 2019. PMID: 30635869 Free PMC article. Review.
-
Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro.Brain Res. 2010 Jan 11;1307:22-7. doi: 10.1016/j.brainres.2009.10.026. Epub 2009 Oct 17. Brain Res. 2010. PMID: 19840779 Free PMC article.
-
The Continued Promise of Neuroprotection for Acute Stroke Treatment.J Exp Stroke Transl Med. 2008;1(1):1-8. doi: 10.6030/1939-067x-1.1.1. J Exp Stroke Transl Med. 2008. PMID: 20198125 Free PMC article.
-
Magnetic resonance characterization of ischemic tissue metabolism.Open Neuroimag J. 2011;5:66-73. doi: 10.2174/1874440001105010066. Epub 2011 Nov 4. Open Neuroimag J. 2011. PMID: 22216079 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical